Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YER087W | AIM10 | SGDID:S000000889 | glyQS glyS TTHA0543 |
Glycine--tRNA ligase (EC 6.1.1.14) (Glycyl-tRNA synthetase) (GlyRS) |
6.1.1.14 | Thermus thermophilus | 1ati_b | P56206 | 99.90 | 1.60E-29 | 9.90E-34 | 253.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | proS EF_2379 |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Enterococcus faecalis | 2j3l_a | Q831W7 | 99.90 | 1.10E-32 | 7.20E-37 | 283.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | Prolyl-tRNA synthetase (EC 6.1.1.15) |
Prolyl-tRNA synthetase (EC 6.1.1.15) |
Naegleria fowleri | 6nab_b | A0A4V8H034 | 100.00 | 6.60E-45 | 4.20E-49 | 369.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YER087W | AIM10 | SGDID:S000000889 | Tc00.1047053507019.40 |
Tc00.1047053507019.40 |
6.1.1.21 | Trypanosoma cruzi | 3lc0_a | Q4DA54 | 99.80 | 1.20E-23 | 7.70E-28 | 209.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | hisS Ta0099 |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Thermoplasma acidophilum | 1wu7_a | Q9HLX5 | 99.70 | 2.70E-22 | 1.70E-26 | 199.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | MST1 YKL194C |
Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) |
6.1.1.3 | Saccharomyces cerevisiae | 3ugt_c | P07236 | 99.90 | 3.50E-29 | 2.20E-33 | 250.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | SARS1 SARS SERS |
Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Homo sapiens | Arteriovenous Malformations Of The Brain,Inclusion Body Myopathy With Early-Onset Paget Disease Of Bone With Or Without Frontotemporal Dementia 2,Inclusion Body Myopathy With Early-Onset Paget Disease Of Bone With Or Without Frontotemporal Dementia 3,Microcephaly,Neurodevelopmental Disorder With Microcephaly, Ataxia, And Seizures,Lynch Syndrome I,Epidemic Typhus,Perrault Syndrome,Inclusion Body Myopathy With Paget Disease Of Bone And Frontotemporal Dementia,Autosomal Recessive Non-Syndromic Intellectual Disability |
3vbb_c | P49591 | ENSG00000031698 | SARS1 | 99.70 | 6.20E-23 | 3.90E-27 | 206.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER087W | AIM10 | SGDID:S000000889 | NEQ417 |
NEQ417 |
6.1.1.14 | Nanoarchaeum equitans | 5z5e_b | Q74N31 | 99.90 | 2.80E-29 | 1.80E-33 | 252.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | ETH_00000045 |
ETH_00000045 |
6.1.1.15 | Eimeria tenella | 5xip_b | U6KWI1 | 100.00 | 1.00E-44 | 6.40E-49 | 366.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | At5g27470 F21A20_180 |
Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Arabidopsis thaliana | 6gir_a | Q39230 | 99.70 | 1.20E-22 | 7.60E-27 | 202.30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | hisS all5012 |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Nostoc sp. | 3net_a | Q8YMC2 | 99.70 | 3.80E-22 | 2.40E-26 | 199.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | serS PH0710 PHCF014 |
Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Pyrococcus horikoshii | 2dq0_a | O58441 | 99.70 | 3.90E-22 | 2.50E-26 | 198.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | serS TT_C0520 |
Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Thermus thermophilus | 1ser_b | P34945 | 99.70 | 1.70E-21 | 1.10E-25 | 192.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | proS TTHA0115 |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Thermus thermophilus | 1h4s_b | Q5SM28 | 100.00 | 6.30E-44 | 4.00E-48 | 359.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | POLG2 MTPOLB |
DNA polymerase subunit gamma-2, mitochondrial (DNA polymerase gamma accessory 55 kDa subunit) (p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta) |
Homo sapiens | Mitochondrial Dna Depletion Syndrome,Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant 1,Myopathy,Mitochondrial Myopathy,Mitochondrial Metabolism Disease,Conjugate Gaze Palsy,Chronic Progressive External Ophthalmoplegia,Mitochondrial Dna Depletion Syndrome 7,Ocular Motility Disease,Autosomal Dominant Progressive External Ophthalmoplegia,Mitochondrial Dna Maintenance Defects,Mitochondrial Disorders,Acute Liver Failure,Visual Cortex Disease,Premature Menopause,Visual Pathway Disease,Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant 4,Mitochondrial Dna Depletion Syndrome 4b,Lactic Acidosis,Mitochondrial Dna Depletion Syndrome 16,Metabolic Acidosis,Sensory Ataxic Neuropathy, Dysarthria, And Ophthalmoparesis,Leber Hereditary Optic Neuropathy, Modifier Of,Mitochondrial Dna Depletion Syndrome 3,Mitochondrial Dna Depletion Syndrome 4a,Kearns-Sayre Syndrome,Leigh Syndrome,Mitochondrial Dna Depletion Syndrome 6,3-Methylglutaconic Aciduria, Type Iii |
2g4c_b | Q9UHN1 | ENSG00000256525 | POLG2 | 99.90 | 2.80E-33 | 1.80E-37 | 280.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YER087W | AIM10 | SGDID:S000000889 | hisS TT_C0360 |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Thermus thermophilus | 1h4v_b | P62374 | 99.70 | 9.20E-23 | 5.80E-27 | 201.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | thrS MW1626 |
Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) |
6.1.1.3 | Staphylococcus aureus | 1nyq_b | Q8NW68 | 99.80 | 4.00E-26 | 2.50E-30 | 239.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | Threonyl-tRNA synthetase (EC 6.1.1.3) |
Threonyl-tRNA synthetase (EC 6.1.1.3) |
6.1.1.3 | Phytophthora sojae | 5zy9_c | G3FIN0 | 99.80 | 6.60E-26 | 4.20E-30 | 223.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | proS MJ1238 |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Methanocaldococcus jannaschii | 1nj8_b | Q58635 | 100.00 | 4.70E-43 | 3.00E-47 | 350.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | SARS2 SARSM |
Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Bos taurus | 1wle_a | Q9N0F3 | 99.70 | 1.10E-22 | 7.00E-27 | 203.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | HARS1 HARS HRS |
Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Homo sapiens | Charles Bonnet Syndrome,Retinitis Pigmentosa,Myopathy,Neuritis,Tremor,Antisynthetase Syndrome,Polymyositis,Low Compliance Bladder,Myositis,Pathologic Nystagmus,Usher Syndrome Type 2,Bagassosis,Oculomotor Apraxia,Sensorineural Hearing Loss,Acute Interstitial Pneumonia,Neuropathy,Charcot-Marie-Tooth Disease,Peripheral Nervous System Disease,Usher Syndrome, Type Iiia,Microcephaly,Tooth Disease,Childhood Type Dermatomyositis,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Aceruloplasminemia,Usher Syndrome,Perrault Syndrome,Vertical Talus, Congenital,Usher Syndrome, Type Iiib,Spastic Ataxia,Charcot-Marie-Tooth Disease, Axonal, Type 2w,Charcot-Marie-Tooth Disease, Axonal, Type 2e,Scoliosis,Ocular Motor Apraxia,Neuronopathy, Distal Hereditary Motor, Type Va |
2lw7_a | P12081 | ENSG00000170445 | HARS1 | 99.10 | 2.20E-14 | 1.40E-18 | 120.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER087W | AIM10 | SGDID:S000000889 | hisS b2514 JW2498 |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Escherichia coli | 1kmm_b | P60906 | 99.70 | 5.00E-23 | 3.20E-27 | 203.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||
YER087W | AIM10 | SGDID:S000000889 | bll0957 |
Amino acid--[acyl-carrier-protein] ligase 1 (EC 6.2.1.n2) (Amino acid:[carrier-protein] ligase [AMP forming] 1) (aa:CP ligase 1) (Aminoacyl-[acyl-carrier-protein] synthetase 1) (L-glycine:[acyl-carrier-protein] ligase 1) |
6.2.1.n2 | Bradyrhizobium diazoefficiens | 3mf2_a | Q89VT8 | 99.60 | 1.20E-19 | 7.70E-24 | 173.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | GL50803_0015983 GL50803_15983 |
GL50803_0015983 GL50803_15983 |
6.1.1.15 | Giardia intestinalis | 3ial_a | A8BR89 | 100.00 | 5.20E-44 | 3.30E-48 | 361.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | hisZ Psyc_0676 |
ATP phosphoribosyltransferase regulatory subunit |
Psychrobacter arcticus | 6ftt_b | Q4FTX3 | 98.80 | 7.30E-13 | 4.60E-17 | 128.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YER087W | AIM10 | SGDID:S000000889 | proS PA0956 |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Pseudomonas aeruginosa | 5ucm_b | Q9I502 | 99.90 | 8.90E-34 | 5.60E-38 | 291.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 |
Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)] |
6.1.1.15,6.1.1.17, | Homo sapiens | Mitochondrial Encephalomyopathy,Muscular Disease,X-Linked Recessive Disease,Chromosomal Disease,Physical Disorder,Glucose Metabolism Disease,Retinitis Pigmentosa,Myopathy,Amino Acid Metabolic Disorder,Connective Tissue Disease,Disorder Of Sexual Development,Robinow Syndrome, Autosomal Recessive 1,Inherited Metabolic Disorder,Muscle Tissue Disease,Charcot-Marie-Tooth Disease, Dominant Intermediate C,Neuromuscular Disease,Mitochondrial Myopathy,Mitochondrial Metabolism Disease,Infantile Liver Failure Syndrome,Antisynthetase Syndrome,Amyotrophic Lateral Sclerosis 1,Combined Oxidative Phosphorylation Deficiency 12,Angelman Syndrome,Eye Degenerative Disease,Microcephaly-Short Stature-Intellectual Disability-Facial Dysmorphism Syndrome,Charcot-Marie-Tooth Disease, Axonal, Type 2d,Motor Neuron Disease,Subependymal Glioma,Benign Ependymoma,Autosomal Dominant Distal Hereditary Motor Neuronopathy,Epilepsy, Idiopathic Generalized 3,Congenital Nervous System Abnormality,Subependymal Giant Cell Astrocytoma,Cardiovascular System Disease,Auditory System Disease,Lung Disease,Acute Cystitis,Parasitic Protozoa Infectious Disease,Trichohepatoenteric Syndrome 1,Pleurisy,Immune System Disease,Nervous System Disease,Inner Ear Disease,Leukodystrophy,Eye Disease,Charcot-Marie-Tooth Disease,Charcot-Marie-Tooth Disease, Axonal, Type 2n,Early Myoclonic Encephalopathy,Peripheral Nervous System Disease,Microcephaly,Dysphagia,Central Nervous System Disease,Cerebral Degeneration,46 Xx Gonadal Dysgenesis,West Syndrome,Disease Of Mental Health,Leukodystrophy, Hypomyelinating, 15,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Respiratory System Disease,Microcephaly, Progressive, With Seizures And Cerebral And Cerebellar Atrophy,Integumentary System Disease,Polyomavirus-Associated Nephropathy,Disease By Infectious Agent,Deafness, Autosomal Recessive 89,Sensory System Disease,Usher Syndrome,Lennox-Gastaut Syndrome,Immune Deficiency Disease,Charcot-Marie-Tooth Disease, Axonal, Type 2u,Neonatal Period Electroclinical Syndrome,Early Infantile Epileptic Encephalopathy,X-Linked Monogenic Disease,Autosomal Recessive Disease,Autosomal Genetic Disease,Perrault Syndrome,Hemorrhagic Cystitis,Pulmonary Disease, Chronic Obstructive,Usher Syndrome, Type Iiib,Epilepsy, Idiopathic Generalized 2,Specific Developmental Disorder,Pervasive Developmental Disorder,Acquired Metabolic Disease,Charcot-Marie-Tooth Disease, Axonal, Type 2e,Robinow Syndrome,Pontocerebellar Hypoplasia,Chromosome 16p11.2 Deletion Syndrome,Chromosomal Duplication Syndrome,Hypomyelinating Leukodystrophy,Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes,Thrombosis,Neuronopathy, Distal Hereditary Motor, Type Va |
4hvc_a | P07814 | ENSG00000136628 | EPRS1 | 100.00 | 8.50E-45 | 5.40E-49 | 368.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER087W | AIM10 | SGDID:S000000889 | hisS TTHA0712 |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Thermus thermophilus | 1ady_d | P56194 | 99.70 | 1.50E-22 | 9.30E-27 | 200.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | 1MB.635 |
1MB.635 |
Cryptosporidium parvum | 5f9z_a | Q7YZ69 | 100.00 | 1.10E-44 | 7.20E-49 | 366.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YER087W | AIM10 | SGDID:S000000889 | serS B4U21_07300 B4U25_08630 BANRA_00987 BL124_00015220 BN49_2024 C2U49_01215 C3F39_05595 C4Y50_030855 CK508_024780 DD581_20470 DD583_13105 DM060_08060 EAO17_23320 EPB11_17925 EXT45_10435 FXN67_16775 G5637_04415 G7Z27_18135 GF489_10680 HV294_16685 NCTC13443_02831 NCTC204_06441 NCTC8849_02140 SAMEA24002668_00735 SAMEA3499901_00033 SAMEA3649466_00865 SAMEA3673122_01272 SAMEA3727579_01463 SAMEA3727679_01559 SAMEA4364603_00207 SAMEA4873581_03803 WP4S18C04_33740 |
serS B4U21_07300 B4U25_08630 BANRA_00987 BL124_00015220 BN49_2024 C2U49_01215 C3F39_05595 C4Y50_030855 CK508_024780 DD581_20470 DD583_13105 DM060_08060 EAO17_23320 EPB11_17925 EXT45_10435 FXN67_16775 G5637_04415 G7Z27_18135 GF489_10680 HV294_16685 NCTC13443_02831 NCTC204_06441 NCTC8849_02140 SAMEA24002668_00735 SAMEA3499901_00033 SAMEA3649466_00865 SAMEA3673122_01272 SAMEA3727579_01463 SAMEA3727679_01559 SAMEA4364603_00207 SAMEA4873581_03803 WP4S18C04_33740 |
6.1.1.11 | Klebsiella pneumoniae | 6h9x_a | W9BNU9 | 99.70 | 9.80E-22 | 6.20E-26 | 194.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | Prolyl-tRNA synthetase (EC 6.1.1.15) |
Prolyl-tRNA synthetase (EC 6.1.1.15) |
Onchocerca volvulus | 6mn8_a | A0A2K6VKP7 | 100.00 | 1.10E-46 | 6.90E-51 | 381.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YER087W | AIM10 | SGDID:S000000889 | serS2 Mbar_A2126 |
Type-2 serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Methanosarcina barkeri | 2cja_b | Q46AN5 | 99.60 | 1.70E-20 | 1.10E-24 | 187.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | SES1 CAALFM_C302780WA CaO19.7901 |
Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Candida albicans | 3qne_a | Q9HGT6 | 99.70 | 1.20E-21 | 7.40E-26 | 196.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | serS aq_298 |
Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Aquifex aeolicus | 2dq3_a | O66647 | 99.60 | 8.60E-21 | 5.50E-25 | 187.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | GARS1 GARS |
Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1) |
6.1.1.14 | Homo sapiens | Spinal Muscular Atrophy With Lower Extremity Predominance,Spinal Muscular Atrophy, Infantile, James Type,Charcot-Marie-Tooth Disease, Type 4a,Charcot-Marie-Tooth Disease Type 5,Charcot-Marie-Tooth Disease, Demyelinating, Type 1c,Cerebral Angioma,Charcot-Marie-Tooth Disease, Dominant Intermediate C,Neuromuscular Disease,Polymyositis,Myositis,Axonal Neuropathy,Neuronopathy, Distal Hereditary Motor, Type Iib,Spinal Muscular Atrophy,Charcot-Marie-Tooth Disease, Axonal, Type 2d,Motor Neuron Disease,Muscular Atrophy,Charcot-Marie-Tooth Disease, Axonal, Type 2l,Spastic Paraplegia 17, Autosomal Dominant,Neuropathy, Hereditary, With Liability To Pressure Palsies,Distal Hereditary Motor Neuropathies,Autosomal Recessive Distal Hereditary Motor Neuronopathy,Autosomal Dominant Distal Hereditary Motor Neuronopathy,Distal Hereditary Motor Neuronopathy Type 2,Motor Peripheral Neuropathy,Bscl2-Related Neurologic Disorders/Seipinopathy,Gars1-Associated Axonal Neuropathy,Dermatomyositis,Neuropathy,Charcot-Marie-Tooth Disease,Charcot-Marie-Tooth Disease, Axonal, Type 2n,Peripheral Nervous System Disease,Thoracic Outlet Syndrome,Tooth Disease,Charcot-Marie-Tooth Disease, Demyelinating, Type 1b,Charcot-Marie-Tooth Disease And Deafness,Charcot-Marie-Tooth Disease, Recessive Intermediate B,Disease Of Mental Health,Brain Stem Infarction,Spinal Muscular Atrophy, Distal, Autosomal Recessive, 1,Charcot-Marie-Tooth Disease, Type 4b2,Scapuloperoneal Spinal Muscular Atrophy,Combined Oxidative Phosphorylation Deficiency 20,Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive,Charcot-Marie-Tooth Disease, Axonal, Type 2b2,Charcot-Marie-Tooth Disease Type X,Charcot-Marie-Tooth Disease Intermediate Type,Spinal Muscular Atrophy, Distal, Autosomal Recessive, 2,Glycine Encephalopathy,Hereditary Motor And Sensory Neuropathy, Type Iic,Charcot-Marie-Tooth Disease, Axonal, Type 2u,Developmental And Epileptic Encephalopathy 29,Charcot-Marie-Tooth Disease, Axonal, Type 2f,Charcot-Marie-Tooth Disease, X-Linked Dominant, 1,Perrault Syndrome,Hypertrophic Neuropathy Of Dejerine-Sottas,Charcot-Marie-Tooth Disease, Axonal, Type 2i,Charcot-Marie-Tooth Disease, Demyelinating, Type 1d,Charcot-Marie-Tooth Disease, Axonal, Type 2e,Hyperekplexia,Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes,Neuronopathy, Distal Hereditary Motor, Type Va,Charcot-Marie-Tooth Disease, Axonal, Type 2b |
2zt5_a | P41250 | ENSG00000106105 | GARS1 | 99.90 | 1.10E-32 | 6.70E-37 | 282.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER087W | AIM10 | SGDID:S000000889 | proS RPA2928 |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Rhodopseudomonas palustris | 2i4l_c | Q6N5P6 | 100.00 | 4.10E-36 | 2.60E-40 | 301.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | thrS-cat thrS1 APE_0809.1 |
Threonine--tRNA ligase catalytic subunit (EC 6.1.1.3) (Threonyl-tRNA synthetase 1) (ThrRS 1) (Threonyl-tRNA synthetase catalytic subunit) (ThrRS-cat) |
6.1.1.3 | Aeropyrum pernix | 3a32_a | Q9YDW0 | 99.90 | 4.20E-29 | 2.60E-33 | 251.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | Tb11.02.5020 |
Tb11.02.5020 |
6.1.1.11 | Trypanosoma brucei | 3lss_b | Q384V4 | 99.60 | 3.80E-20 | 2.40E-24 | 184.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | serS MK1460 |
Type-2 serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Methanopyrus kandleri | 3w3s_a | Q8TVD2 | 99.60 | 4.20E-20 | 2.60E-24 | 183.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | proS MTH_611 |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Methanothermobacter thermautotrophicus | 1nj1_a | O26708 | 100.00 | 1.20E-44 | 7.60E-49 | 365.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | serS TTHA0875 |
Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) |
6.1.1.11 | Thermus thermophilus | 3err_b | Q5SJX7 | 99.60 | 6.40E-20 | 4.10E-24 | 187.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | Polg2 Mtpolb |
DNA polymerase subunit gamma-2, mitochondrial (DNA polymerase gamma accessory 55 kDa subunit) (p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta) |
Mus musculus | 1g5h_d | Q9QZM2 | 99.90 | 3.90E-31 | 2.50E-35 | 263.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
YER087W | AIM10 | SGDID:S000000889 | TARS1 TARS |
Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1) |
6.1.1.3 | Homo sapiens | Antisynthetase Syndrome,Polymyositis,Myositis,Chromosome 5p13 Duplication Syndrome,Trichothiodystrophy,Trichothiodystrophy 7, Nonphotosensitive |
4hwt_a | P26639 | ENSG00000113407 | TARS1 | 99.90 | 3.60E-28 | 2.30E-32 | 240.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER087W | AIM10 | SGDID:S000000889 | hisS |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Staphylococcus aureus | 1qe0_a | P60911 | 99.80 | 2.20E-24 | 1.40E-28 | 213.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | proRS PFL0670c |
Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS) |
6.1.1.15 | Plasmodium falciparum | 4twa_a | Q8I5R7 | 100.00 | 1.30E-45 | 8.40E-50 | 373.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | hisS ABSDF3000 |
Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS) |
6.1.1.21 | Acinetobacter baumannii | 5e3i_a | B0VKR7 | 99.70 | 3.60E-22 | 2.30E-26 | 198.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | LMJF_18_1220 |
LMJF_18_1220 |
6.1.1.15 | Leishmania major | 5xil_a | Q4QDS0 | 100.00 | 6.10E-45 | 3.80E-49 | 369.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER087W | AIM10 | SGDID:S000000889 | hisZ BH3584 |
ATP phosphoribosyltransferase regulatory subunit |
Bacillus halodurans | 3od1_a | Q9K6Z0 | 99.40 | 4.80E-17 | 3.10E-21 | 158.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YER087W | AIM10 | SGDID:S000000889 | thrS b1719 JW1709 |
Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) |
6.1.1.3 | Escherichia coli | 1kog_h | P0A8M3 | 99.90 | 4.00E-27 | 2.50E-31 | 232.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |